-
Study aim
-
Effect of Curcumin Supplement on Mood, Lipid, Glycemic and Oxidative Stress, hs-CRP, in PCOS
-
Design
-
In this double-blind, randomized, parallel clinical trial study, 60 patients with PCOS referring to Fertility and Infertility Centers in Isfahan who have criteria for entering the study are described by the available sampling method. The subject, goals and method of studying the study are described. Those people who have been diagnosed with a PCOS diagnosis by a doctor and whose disease has become stable and who does not have severe fluctuations in blood parameters, so that they receive a certain dose of medication for their illness , If they wish to participate in this study, they will receive written consent
-
Settings and conduct
-
In this interventional study, 60 patients with PCOS referring to Fertility and Infertility Centers in Isfahan who have criteria for entering the study are described by the available sampling method. The subject, goals and method of studying the study are described.
-
Participants/Inclusion and exclusion criteria
-
Inclination to participate in the study, the diagnosis of PCOS by a specialist (based on Rotterdam criteria); a group of 18 to 40 years of age; a BMI greater than 25 and less than 35; a fixed type and dosage of medications within 6 Last month; acute and chronic diseases; antioxidant supplements; or any treatment affecting inflammatory factors and oxidative stress biomarkers during the past 6 months
-
Intervention groups
-
Patients are randomly blocked divided into the group receiving the supplement of curcumin and placebo. Patients in the group receiving the supplement of curcumin from karen company (n = 30) for 6 weeks daily 1 g (500 mg twice daily) as Capsules, while patients in the placebo group (n = 30) will receive similar capsules with starch during the study
-
Main outcome variables
-
Glycemic Indexes, lipids and Oxidative Stress; hs-CRP; Mood